RecruitingNCT06311149

Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Multicenter Evaluation of Patients Using LATITUDE Monitoring System: Multitude Study


Sponsor

University Hospital of Ferrara

Enrollment

20,000 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database. The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice. The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.


Eligibility

Inclusion Criteria4

  • Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation.
  • Subject is:
  • prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system
  • retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system

Exclusion Criteria2

  • Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device.
  • Subject is receiving a device that is not approved for commercial use at the time of procedure.

Locations(3)

Azienda Ospedaliero-Universitaria di Ferrara

Ferrara, Italy

Policlinico Federico II

Napoli, Italy

Ospedale "G.B. Grassi"

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06311149


Related Trials